BOSTON, Jan. 08, 2026 -- Aktis Oncology, Inc. (“Aktis”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed...
Charles Hsu will be a keynote speaker at the annual meeting of the Sino-American Pharmaceutical Association (West) in San Francisco
News | 04. 15. 2006
